Active Surveillance for Prostate Cancer: Expanding the Role of MR Imaging and the Use of PRECISE Criteria

Radiol Clin North Am. 2024 Jan;62(1):69-92. doi: 10.1016/j.rcl.2023.06.009. Epub 2023 Aug 21.

Abstract

Multiparametric magnetic resonance (MR) imaging has had an expanding role in active surveillance (AS) for prostate cancer. It can improve the accuracy of prostate biopsies, assist in patient selection, and help monitor cancer progression. The PRECISE recommendations standardize reporting of serial MR imaging scans during AS. We summarize the evidence on MR imaging-led AS and provide a clinical primer to help report using the PRECISE criteria. Some limitations to both serial imaging and the PRECISE recommendations must be considered as we move toward a more individualized risk-stratified approach to AS.

Keywords: Active surveillance; Biopsy; MRI; PRECISE; Prostate cancer; mpMRI.

Publication types

  • Review

MeSH terms

  • Humans
  • Image-Guided Biopsy
  • Magnetic Resonance Imaging / methods
  • Male
  • Multiparametric Magnetic Resonance Imaging*
  • Prostate / diagnostic imaging
  • Prostate / pathology
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology
  • Watchful Waiting